Epclusa Made Available to Hepatitis C Patients via Taiwan’s NHI
Epclusa is the first approved single tablet regimen to treat all six major genotypes of hepatitis C virus. Gilead Sciences announced that Epclusa (sofosbuvir 400mg/velpatasvir 100mg), a once daily...